NUBURU Names Brian Knaley as Chief Financial Officer
Three-time public company CFO joins NUBURU with deep experience in leading business transformation and optimization of financial processes on a global scale
OTI Lumionics and UBC Demonstrate Quantum Computing Methods to be Effective in Simulating OLED Display Material Properties
Published in Angewandte Chemie International Edition, researchers found that quantum computing methods can accurately predict the colour of light emission from OLED emitter materials
6K and Our Next Energy (ONE) Announce Collaboration to Create Low-Cost Gemini Cathode Material
The new material, produced on 6K’s UniMelt® microwave plasma production system, will be used in ONE’s range-extended Gemini battery system.
Niron Magnetics Receives Strategic Investment from Western Digital Capital
Investment to accelerate next-generation Clean Earth Magnet™ development for use in hard disk drives for enterprise cloud storage, data centers and more
ImmunoScape Inks Licensing Deal with Pure MHC to Advance Development of Novel TCR-Based Therapies
ImmunoScape will utilize Pure MHC’s library of T cell antigens specific to tumor cells to accelerate identification of novel T cell receptors using its Deep Immunomics platform
AML100 boosts battery life by up to 20x with innovative system-level approach to always-on power reduction
The AML100 boosts battery life by up to 20x with an innovative system-level approach to always-on power reduction
BioSkryb Genomics and ALS Automated Lab Solutions GmbH Sign U.S. Distribution Agreement to Power Unprecedented Single Cell Spatial Genomics
The agreement combines industry-leading technologies, enabling single cell selection and genome sequencing, and supports the development of intact tissue sample analysis
NTx Awarded Grant to Develop Novel Manufacturing Technologies for Improved Global Access to mRNA Vaccines and Therapeutics
NTx has received a grant from the Bill & Melinda Gates Foundation to develop new production approaches to lower the cost and improve access to mRNA vaccines and therapeutics for low- and middle-income countries
GelSight Expands its Board of Directors to Guide Transformation into Tactile Intelligence Platform Company
MAKO and Magic Leap founder Rony Abovitz and experienced executive and investor Elliot Katzman will help shape GelSight’s strategy and reach
Excision BioTherapeutics Initiates Phase 1/2 Trial Evaluating EBT-101 as a Potential Cure for HIV
First-in-human trial is now open for enrollment for EBT-101, a CRISPR-based therapeutic being developed as a potential functional cure for people living with HIV